The human skull is about a quarter of an inch of solid bone, perfectly suited to perform its role as the protector of one of the most sensitive organs of the body, the brain. In the event of brain swelling (clinically referred to as cerebral oedema), an excess of fluid floods brain tissues and spikes

Watching the Biology of Brain Swelling in Real Tim Read More »

Bharat Biotech, a biotechnology company in India, is expected to be the first to offer a COVID-19 nasal spray vaccine with their phase 3 trials now underway. This nasal vaccine is intended to be used as a booster to mRNA vaccines rather than a primary vaccine. That’s because nasal vaccines are thought not to provide enough of

COVID-19 Nasal Spray Vaccines in the Making Read More »

Magnesium deficiency is associated with some types of cancer, including breast, ovarian, and kidney cancer.  Pre-clinical studies have demonstrated that, while inhibiting primary tumor growth, a low magnesium diet promoted tumor metastasis.  The current literature on cancer and magnesium is incomplete and lacks large-scale controlled clinical trials.  Additionally, any immunological mechanism describing how magnesium, or lack thereof, influences cancer growth

Can Magnesium Help the Immune System Fight Cancer? Read More »

Scientists have identified a common genetic risk factor for the loss of smell due to COVID-19. Six months after testing positive for COVID-19, 1.6 million people in the US have experienced changes to their sense of smell, including the loss of smell entirely. Loss of smell and taste are distinctive symptoms of COVID-19 and are

Genetic Risk Factor Identified for COVID-19 Loss of Smell Read More »

Now that Omicron is running through the globe and increasing exposure to SARS-CoV-2 more than any previous variant, scientists are optimistic that there may be a much-welcomed extended period of quiet after this wave ends. According to data, a country’s vaccination rate alone doesn’t clearly correlate with its COVID death rate. For instance, as would

What Happens After Omicron? Scientists’ Predictions Read More »

The Swiss biotech company Idorsia announced this week that it has received approval from the United States Food and Drug Administration (FDA) for its new drug that can help adult patients treat their insomnia. The sleeping pill, called Quviviq (daridorexant) is the first drug created by Idorsia that has received approval from the FDA, and, pending scheduling

The FDA grants approval for a new insomnia drug to improve sleep in adults Read More »

Project “Development of a Cloud Platform for Patient-Oriented Telerehabilitation of Cancer Patients Based on Mathematical Modeling” Won in the Competition On December 7, 2021, the Scientific Council of National Research Foundation of Ukraine published the ranking of projects joining the competition “Science for Security and Sustainable Development of Ukraine”, which were submitted in 2021. A

Project “Development of a Cloud Platform for Patient-Oriented Telerehabilitation of Cancer Patients Based on Mathematical Modeling” Won in the Competition Read More »

Novavax, a Maryland-based biotechnology company, gets approval for its more traditional protein-subunit COVID-19 vaccine, offering an alternative to newer mRNA and viral vector vaccine options. Pfizer-BioNTech’s COVID-19 vaccine is the only mRNA vaccine to be FDA approved, and mRNA vaccines are relatively new, making some skeptical of them. These vaccines work by delivering mRNA into

Novavax’s More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization Read More »

Scroll to Top